Literature DB >> 12515679

A 2-year dose-response study of lesion sequences during hepatocellular carcinogenesis in the male B6C3F(1) mouse given the drinking water chemical dichloroacetic acid.

Julia H Carter1, Harry W Carter, James A Deddens, Bernadette M Hurst, Michael H George, Anthony B DeAngelo.   

Abstract

Dichloroacetic acid (DCA) is carcinogenic to the B6C3F(1) mouse and the F344 rat. Given the carcinogenic potential of DCA in rodent liver and the known concentrations of this compound in drinking water, reliable biologically based models to reduce the uncertainty of risk assessment for human exposure to DCA are needed. Development of such models requires identification and quantification of premalignant hepatic lesions, identification of the doses at which these lesions occur, and determination of the likelihood that these lesions will progress to cancer. In this study we determined the dose response of histopathologic changes occurring in the livers of mice exposed to DCA (0.05-3.5 g/L) for 26-100 weeks. Lesions were classified as foci of cellular alteration smaller than one liver lobule (altered hepatic foci; AHF), foci of cellular alteration larger than one liver lobule (large foci of cellular alteration; LFCA), adenomas (ADs), or carcinomas (CAs). Histopathologic analysis of 598 premalignant lesions revealed that (a)) each lesion class had a predominant phenotype; (b)) AHF, LFCA, and AD demonstrated neoplastic progression with time; and (c)) independent of DCA dose and length of exposure effects, some toxic/adaptive changes in non-involved liver were related to this neoplastic progression. A lesion sequence for carcinogenesis in male B6C3F(1) mouse liver has been proposed that will enable development of a biologically based mathematical model for DCA. Because all classes of premalignant lesions and CAs were found at both lower and higher doses, these data are consistent with the conclusion that nongenotoxic mechanisms, such as negative selection, are relevant to DCA carcinogenesis at lower doses where DCA genotoxicity has not been observed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12515679      PMCID: PMC1241306          DOI: 10.1289/ehp.5442

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  35 in total

1.  Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action.

Authors:  A B DeAngelo; M H George; D E House
Journal:  J Toxicol Environ Health A       Date:  1999-12-24

2.  Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids.

Authors:  A B DeAngelo; F B Daniel; L McMillan; P Wernsing; R E Savage
Journal:  Toxicol Appl Pharmacol       Date:  1989-11       Impact factor: 4.219

Review 3.  Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia.

Authors:  P Bannasch
Journal:  Carcinogenesis       Date:  1986-05       Impact factor: 4.944

4.  Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice.

Authors:  M A Pereira
Journal:  Fundam Appl Toxicol       Date:  1996-06

Review 5.  Epigenetic mechanisms of chemical carcinogenesis.

Authors:  J E Klaunig; L M Kamendulis; Y Xu
Journal:  Hum Exp Toxicol       Date:  2000-10       Impact factor: 2.903

6.  The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver.

Authors:  S L Herren-Freund; M A Pereira; M D Khoury; G Olson
Journal:  Toxicol Appl Pharmacol       Date:  1987-09-15       Impact factor: 4.219

7.  A morphologic classification of proliferative and neoplastic hepatic lesions in mice.

Authors:  C H Frith; J M Ward
Journal:  J Environ Pathol Toxicol       Date:  1979-12

8.  Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia.

Authors:  P W Stacpoole; G W Moore; D M Kornhauser
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

9.  Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogenesis utilizing the GST-P positive liver cell focus as an endpoint marker.

Authors:  N Ito; M Tatematsu; R Hasegawa; H Tsuda
Journal:  Toxicol Pathol       Date:  1989       Impact factor: 1.902

10.  Advantages and limitations of stereological estimation of placental glutathione S-transferase-positive rat liver cell foci by computerized three-dimensional reconstruction.

Authors:  K Imaida; M Tatematsu; T Kato; H Tsuda; N Ito
Journal:  Jpn J Cancer Res       Date:  1989-04
View more
  10 in total

1.  The Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia.

Authors:  Kenneth J Salleng; Frank L Revetta; Natasha G Deane; M Kay Washington
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

2.  Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.

Authors:  Peter Bannasch
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

3.  Helicobacter hepaticus--induced liver tumor promotion is associated with increased serum bile acid and a persistent microbial-induced immune response.

Authors:  Alexis García; Yu Zeng; Sureshkumar Muthupalani; Zhongming Ge; Amanda Potter; Melissa W Mobley; Chakib Boussahmain; Yan Feng; John S Wishnok; James G Fox
Journal:  Cancer Res       Date:  2011-02-18       Impact factor: 12.701

4.  Toxicity and carcinogenicity of the water disinfection byproduct, dibromoacetic acid, in rats and mice.

Authors:  Ronald L Melnick; Abraham Nyska; Paul M Foster; Joseph H Roycroft; Grace E Kissling
Journal:  Toxicology       Date:  2006-12-08       Impact factor: 4.221

5.  Evaluation of dichloroacetic acid for carcinogenicity in genetically modified Tg.AC hemizygous and p53 haploinsufficient mice.

Authors:  Grace E Kissling; David E Malarkey; Molly K Vallant; Jerry D Johnson; Milton R Hejtmancik; Ronald A Herbert; Gary A Boorman
Journal:  Toxicol Sci       Date:  2008-10-30       Impact factor: 4.849

6.  Physiologically based pharmacokinetic modeling of dibromoacetic acid in F344 rats.

Authors:  Jessica L Matthews; Irvin R Schultz; Michael R Easterling; Ronald L Melnick
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

7.  Bicarbonate and dichloroacetate: evaluating pH altering therapies in a mouse model for metastatic breast cancer.

Authors:  Ian F Robey; Natasha K Martin
Journal:  BMC Cancer       Date:  2011-06-10       Impact factor: 4.430

Review 8.  Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.

Authors:  Jane C Caldwell; Nagalakshmi Keshava
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

9.  NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas.

Authors:  Sara M Reed; Jussara Hagen; Viviane P Muniz; Timothy R Rosean; Nick Borcherding; Sebastian Sciegienka; J Adam Goeken; Paul W Naumann; Weizhou Zhang; Van S Tompkins; Siegfried Janz; David K Meyerholz; Dawn E Quelle
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 10.  The Importance of Gender-Related Anticancer Research on Mitochondrial Regulator Sodium Dichloroacetate in Preclinical Studies In Vivo.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Eligija Damanskienė; Angelija Valančiūtė; Ingrida Balnytė; Marta Maria Alonso
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.